VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 25 filers reported holding VASCULAR BIOGENICS LTD in Q1 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $186,000 | -57.5% | 41,691 | -47.6% | 0.12% | -57.0% |
| Q1 2017 | $438,000 | -55.6% | 79,611 | -60.9% | 0.28% | -28.8% |
| Q4 2016 | $987,000 | -40.8% | 203,461 | -36.3% | 0.40% | -27.7% |
| Q3 2016 | $1,668,000 | +65.6% | 319,509 | +46.2% | 0.55% | +74.7% |
| Q2 2016 | $1,007,000 | – | 218,500 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |